68Ga-Fibroblast Activation Protein Inhibitor, a Promising Radiopharmaceutical in PET/CT to Detect the Primary and Metastatic Lesions of Chromophobe Renal Cell Carcinoma.
Clin Nucl Med
; 46(2): 177-179, 2021 Feb 01.
Article
en En
| MEDLINE
| ID: mdl-33315682
ABSTRACT
ABSTRACT 18F-FDG PET/CT was performed to locate the primary lesion in a 71-year-old man with bone metastasis. However, no abnormal 18F-FDG activity likely presenting the primary tumor was observed. 68Ga-fibroblast activation protein inhibitor PET/CT was then performed for further detecting the primary tumor, which showed a higher activity in lesions of bone metastases than 18F-FDG. Additionally, another lesion with intense uptake was observed in the inferior pole of right kidney, likely presenting the primary tumor. A renal biopsy revealed the diagnosis of chromophobe renal cell carcinoma. This case highlighted that 68Ga-fibroblast activation protein inhibitor could be a promising radiopharmaceutical in the diagnosis of renal cell carcinoma.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Quinolinas
/
Carcinoma de Células Renales
/
Tomografía Computarizada por Tomografía de Emisión de Positrones
/
Neoplasias Renales
Límite:
Aged
/
Humans
/
Male
Idioma:
En
Revista:
Clin Nucl Med
Año:
2021
Tipo del documento:
Article